Bisphosphonate's and Intermittent Parathyroid Hormone's Effect on Human Spinal Fusion: A Systematic Review of the Literature [PDF]
Asian Spine Journal, 2017 There has been a conscious effort to address osteoporosis in the aging population. As bisphosphonate and intermittent parathyroid hormone (PTH) therapy become more widely prescribed to treat osteoporosis, it is important to understand their effects on ...
Michael A. Stone +9 more
doaj +4 more sources
Influence of bisphosphonates on alveolar bone density: a histomorphometric analysis [PDF]
Brazilian Oral Research, 2010 This study is a histomorphometrical analysis of the influence of the bisphosphonate alendronate on alveolar bone density. Eighteen male Wistar rats were randomly assigned to a control group (n = 9) that received no medication and an experimental group (n
Milton Santamaria Júnior +3 more
doaj +4 more sources
Molecular theranostics: principles, challenges and controversies. [PDF]
J Med Radiat SciMolecular theranostics offers a powerful tool to drive precision medicine in nuclear oncology. While theranostics is not a new principle in nuclear medicine, recent advances in instrumentation and radiopharmacy have driven a reinvigoration and a broader suite of applications.
Currie G.
europepmc +2 more sources
Osteonecrosis of the jaw as a serious adverse effect of bisphosphonate therapy and its indistinct etiopathogenesis [PDF]
Vojnosanitetski Pregled, 2014 nema
Gavrić Miodrag +6 more
doaj +1 more source
Effects of red and infrared laser on post extraction socket repair in rats subjected to alendronate therapy [PDF]
Brazilian Oral Research, 2023 This study evaluated the effect of photobiomodulation therapy (PBMT) with a red or infrared laser on the repair of post extraction sockets in rats administered alendronate (ALN).
Fernanda Castanheira GONÇALVES +4 more
doaj +1 more source
Obesity influences the development of bisphosphonate-induced osteonecrosis in Wistar rats [PDF]
Journal of Applied Oral Science, 2023 Medication-related osteonecrosis of the jaw (MRONJ) is characterized by bone exposure for more than eight weeks in patients who have used or been treated with antiresorptive or antiangiogenic drugs, without a history of radiation therapy or metastatic ...
Wilson José de Miranda LIMA +7 more
doaj +1 more source
Prevention of medication-related osteonecrosis of the jaws secondary to tooth extractions: a systematic review [PDF]
, 2016 Background: A study was made to identify the most effective protocol for reducing the risk of osteonecrosis of the jaws (ONJ) following tooth extraction in patients subjected to treatment with antiresorptive or antiangiogenic drugs. Material and Methods:
Diniz Freitas, Márcio +1 more
core +4 more sources
Drugs in Context, 2020 Background: On stopping bisphosphonate treatment, bone resorption may increase before evidence of a decrease in bone density. Offset of bisphosphonate effect may therefore be monitored by measuring C-terminal telopeptide (CTX) following long-term ...
Louise Statham +2 more
doaj +1 more source
Use of disodium pamidronate bisphosphonate in patients with bone metastases of lung cancer [PDF]
Vojnosanitetski Pregled, 2002 Disodium pamidronate (Aredia®), a drug of the bisphosphonate group, was administered to 20 patients with pains in the bones due to secondary deposits of lung cancer.
Ranković Boško, Mrđa Vladimir
doaj +1 more source
Diagnostics, 2021 Complex regional pain syndrome type I (CRPS I)—or algodystrophy—is a rare disease that usually occurs after a traumatic event. It is characterized by typical clinical findings such as severe and disabling pain disproportionate to the injury, functional ...
Antimo Moretti +6 more
doaj +1 more source